Ignite Creation Date:
2024-05-05 @ 7:45 PM
Last Modification Date:
2024-10-26 @ 9:53 AM
Study NCT ID:
NCT00730561
Status:
COMPLETED
Last Update Posted:
2008-08-08
First Post:
2008-07-31
Brief Title:
Hematopoietic Stem Cell Transplantation for the Treatment of Limb Ischemia and Diabetic Neuropathy
Sponsor:
Hospital Universitario Dr Jose E Gonzalez
Organization:
Hospital Universitario Dr Jose E Gonzalez
Study Overview
Official Title:
Autologous Hematopoietic Stem Cell Transplantation for the Treatment of Limb Ischemia and Diabetic Neuropathy in Patients With Diabetes Mellitus Type 2A Randomized Controlled Trial
Status:
COMPLETED
Status Verified Date:
2008-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Several pathophysiological theories have been proposed for the development of diabetic chronic complications In recent years the use of stem cells totipotential hematopoietic or endothelial lineages has been reported as an adjunctive modality of treatment for ischemia models in animals and humans Nevertheless there are no reports in the use of stem cells for the treatment of human sensorimotor peripheral diabetic neuropathy We performed this study to evaluate the effect of autologous hematopoietic CD34 cell transplantation on nerve conduction velocity in patients with type 2 diabetes mellitus
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None